Status:
COMPLETED
Association of Physical Activity Levels and Inflammatory Markers Following Pulmonary Rehabilitation
Lead Sponsor:
University of Lincoln
Collaborating Sponsors:
National Health Service, United Kingdom
Conditions:
COPD
Eligibility:
All Genders
40-90 years
Brief Summary
COPD is characterised by irreversible airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response. This inflammation can be amplified with flare-ups th...
Eligibility Criteria
Inclusion
- Patients diagnosed with any severity of COPD (according to British Thoracic Society criteria, i.e. \>10 pack year smoking history and post bronchodilator spirometry FEV1/FVC ratio \<0.70 and FEV\<80%)
- Previously enrolled on pulmonary rehabilitation providing at least one sample for the CIMPRES-COPD trial.
Exclusion
- Any unstable ongoing cardiovascular events.
- Other active inflammatory conditions (e.g. rheumatoid arthritis, cancer).
- Known asthma, allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis).
Key Trial Info
Start Date :
May 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 2 2018
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03455153
Start Date
May 2 2018
End Date
October 2 2018
Last Update
October 9 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Lindum Medical Practice
Lincoln, Lincolnshire, United Kingdom, LN2 2JP
2
Nettleham Medical Practice
Lincoln, Lincolnshire, United Kingdom, LN2 2RS
3
Birchwood Medical Practice
Lincoln, Lincolnshire, United Kingdom, LN6 0QQ